一例报告：瑞舒伐他汀致80岁女性横纹肌溶解。

Q4 Medicine

South Dakota medicine : the journal of the South Dakota State Medical Association Pub Date : 2024-11-01

Muhammad Hasan, Mohammad Ahmed

{"title":"一例报告：瑞舒伐他汀致80岁女性横纹肌溶解。","authors":"Muhammad Hasan, Mohammad Ahmed","doi":"","DOIUrl":null,"url":null,"abstract":"Rosuvastatin, a commonly prescribed lipid-lowering medication for primary and secondary prevention of cardiovascular disease, is generally considered safe with associated mortality benefits. Despite its overall safety profile, the drug is not without side effects. Statin-induced myopathy, a known complication, can manifest in 10-25% of cases, while more uncommon complications such as rhabdomyolysis occur in less than 0.1% of treated patients. In this case report, we present an 80-year-old female presenting with rhabdomyolysis attributable to rosuvastatin.","PeriodicalId":39219,"journal":{"name":"South Dakota medicine : the journal of the South Dakota State Medical Association","volume":"77 11","pages":"501-502"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Case Report: Rosuvastatin Induced Rhabdomyolysis in an 80-Year-Old Female.\",\"authors\":\"Muhammad Hasan, Mohammad Ahmed\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Rosuvastatin, a commonly prescribed lipid-lowering medication for primary and secondary prevention of cardiovascular disease, is generally considered safe with associated mortality benefits. Despite its overall safety profile, the drug is not without side effects. Statin-induced myopathy, a known complication, can manifest in 10-25% of cases, while more uncommon complications such as rhabdomyolysis occur in less than 0.1% of treated patients. In this case report, we present an 80-year-old female presenting with rhabdomyolysis attributable to rosuvastatin.\",\"PeriodicalId\":39219,\"journal\":{\"name\":\"South Dakota medicine : the journal of the South Dakota State Medical Association\",\"volume\":\"77 11\",\"pages\":\"501-502\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South Dakota medicine : the journal of the South Dakota State Medical Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Dakota medicine : the journal of the South Dakota State Medical Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

瑞舒伐他汀是一种常用的用于一级和二级预防心血管疾病的降脂药物，通常被认为是安全的，并具有相关的死亡率降低。尽管总体上是安全的，但这种药物并非没有副作用。他汀类药物引起的肌病是一种已知的并发症，可在10-25%的病例中表现出来，而更罕见的并发症，如横纹肌溶解，发生在不到0.1%的治疗患者中。在这个病例报告中，我们报告了一位80岁的女性，因瑞舒伐他汀而出现横纹肌溶解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

A Case Report: Rosuvastatin Induced Rhabdomyolysis in an 80-Year-Old Female.

Rosuvastatin, a commonly prescribed lipid-lowering medication for primary and secondary prevention of cardiovascular disease, is generally considered safe with associated mortality benefits. Despite its overall safety profile, the drug is not without side effects. Statin-induced myopathy, a known complication, can manifest in 10-25% of cases, while more uncommon complications such as rhabdomyolysis occur in less than 0.1% of treated patients. In this case report, we present an 80-year-old female presenting with rhabdomyolysis attributable to rosuvastatin.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

South Dakota medicine : the journal of the South Dakota State Medical Association Medicine-Medicine (all)

CiteScore

0.50

自引率

0.00%

发文量